In summary, although our in vitro experiments provide preliminary insights into the regulatory role of GADD45G in glioma cell migration, invasion, and EMT-like transitions, further systematic mechanistic studies and validations using clinical specimens and animal models are required to fully establish its prognostic and therapeutic potential. This evidence concerns the gene GADD45G and central nervous system cancer.